Searched for
GVK BIO DATA
Aragen acquires Pune-based pre-clinical research provider IntoxAragen Life Sciences signs a definitive agreement to acquire Pune-based Intox Pvt. Ltd. The Hyderabad-based Aragen, which was formerly call...- Private equity fund True North acquires minority stake in Bengaluru-based Anthem BioSet up by ex-Biocon executive Ajay Bharadwaj, Rs.1200-crore Anthem Biosciences competes with Biocon owned Syngene International and Hyderab...
- Goldman, Temasek, Carlyle vie for 30% stake in GVK BioInvestor will buy out ChrysCapital stake; co-promoters looking to monetise holding
- 145 firms under additional surveillance measure framework: BSEPublic sector enterprises and public sector banks are excluded from the ASM framework.
- What debt can do: Will this smallcap become a Rs 1 lakh crore firm some day?The company has not reported quarterly profit since September quarter of FY12.
- ChrysCapital sells 3% in Intas to Capital InternationalChrysCapital will continue to hold a 3% stake in Intas, making it the longest and probably the most successful private equity investment in...
- Government panel looking into GVK Bio data issue, says officialThe concerns raised by French drug regulator ANSM over the data integrity of GVK Bio have no basis, a senior official said.
- Germany suspends marketing of 54 drugs tested by GVK BiosciencesGermany's drug regulator has suspended the marketing of 54 medicines clinically tested by India's GVK Biosciences in compliance.
- India may contest EU move to ban 700 drugsIndia may contest a decision by the European drug regulator to recommend a ban on as many as 700 generic products tested by GVK Biosciences
- EU bans 700 generic drugs for manipulation of trials by GVK BiosciencesMedicines affected by the sales ban will lose their validity for use in the EU and they should no longer be sold by pharmaceutical companie...
- Lupin submits fresh studies for two products suspended by EMALupin said that company has successfully conducted the new bio equivalence (BE) studies for the said products and submitted the report to E...
- German regulator hails European Medicine Agency's drugs suspension on GVK Bio dataThe German watchdog said it will take a decision shortly on whether to add more medicines to the list of banned drugs in the wake of the EM...
- EU regulator recommends suspension of drugs over GVK Bio dataThe recommendation is based on findings from an inspection that raised concerns about how GVK conducted studies at the Hyderabad site on be...
- German ban on generic drugs not applicable to 18 of themMedicines affected by the suspension of marketing authorisation will be allowed to resume sales if the companies furnish fresh clinical tri...
- Germany bans 80 generic drugs for insufficient trials by GVKThe regulator said it had informed the drugs manufacturers about its decision on Monday and the ban on the sales of medicines came into eff...
- European Union health regulators suspect manipulation by GVK BioRegulators in many European countries including Germany are reportedly evaluating whether to suspend the use of over 100 medicines.
- GVK Bio under scanner of European Drug RegulatorThe review of medicines for which studies have been conducted by GVK Bio has been initiated at the request of the European Commission.
- GVK Bio under scanner of European Drug RegulatorThe review of medicines for which studies have been conducted by GVK Bio has been initiated at the request of the European Commission.
- Sequoia plans to sell its 20% stake in GVK Biosciences“The fund is looking at earning over three times returns on its investment in GVK Bio. Currently, its stake is being valued at around Rs 31...
- DCGI checks clinical trial data on Wyeth’s pneumonia vaccineThe Drug Controller General of India (DCGI) has scrutinised the clinical trial data of the advanced pneumonia vaccine developed by the US-b...
Load More
